• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Sectors Health

NAFDAC warns Nigerians on MR.7 SUPER 700000 capsules recall

Rosalia Ozibo by Rosalia Ozibo
March 18, 2026
in Health, Sectors
NAFDAC warns Nigerians on MR.7 SUPER 700000 capsules recall
Share on FacebookShare on TwitterShare on Linkedin

The National Agency for Food and Drug Administration and Control has alerted Nigerians to the recall of MR.7 SUPER 700000 capsules, a product marketed online as a dietary supplement for male enhancement.

This was disclosed in a public notice issued by the agency.

According to the regulator, the manufacturer, StuffbyNainax LLC, is voluntarily recalling all available lots of the product after an analysis found the capsules contained undeclared pharmaceutical ingredients.

MoreStories

Lagos seals non-LASRERA certified estate agent office in Ikorodu

Lagos seals non-LASRERA certified estate agent office in Ikorodu

March 20, 2026
FG refutes false claims of religious genocide in Nigeria  

Nigeria ready to contribute oil to ease global tension – Minister

March 20, 2026

What NAFDAC said 

According to the agency, the recall followed an analysis which found that MR.7 SUPER 700000 capsules contained sildenafil and tadalafil, substances commonly used in prescription medicines for the treatment of erectile dysfunction.

  • “The recall follows an FDA analysis, which found “MR.7 SUPER 700000’’ capsules to contain undeclared ingredients (tadalafil and sildenafil). Sildenafil and tadalafil are phosphodiesterase (PDE-5) inhibitors found in FDA-approved products for the treatment of male erectile dysfunction 
  • “The presence of sildenafil and tadalafil in “MR.7 SUPER 700000’’ capsules renders them unapproved drugs for which safety and efficacy have not been established and, therefore, subject to recall,” they stated. 

NAFDAC explained that the presence of these substances makes the capsules unapproved drugs, since the product is marketed as a dietary supplement and its safety and efficacy have not been established.

  • “Consumption of products containing undeclared sildenafil or tadalafil may cause serious health risks,” the agency stated. 

More details 

NAFDAC noted that the substances may interact with nitrates used in certain prescription medicines, such as nitroglycerin, which are commonly prescribed for heart conditions.

The interaction could result in a dangerous drop in blood pressure, which may be life-threatening.

According to the agency, individuals with diabetes, high blood pressure, high cholesterol, or heart disease are particularly vulnerable because they often take nitrate-based medications

The agency provided the following details about the recalled product:

  • Product name: MR.7 SUPER 700000
  • Manufacturer: StuffbyNainax LLC
  • Batch number: All available lots
  • Product form: Capsules
  • Product description: Dietary supplement marketed for male enhancement

NAFDAC urged members of the public who have the product to stop selling or using it immediately and return it to the nearest NAFDAC office.

Consumers were also encouraged to report compromised medicines or medical devices to the nearest NAFDAC office, through the agency’s toll-free line 0800-162-3322, or via email at sf.alert@nafdac.gov.ng

What you should know 

NAFDAC recently alerted Nigerians to a Notice of Concern issued by the World Health Organization’s Prequalification Service over four NAFDAC-registered diagnostic kits manufactured by Meril Diagnostics Pvt. Ltd in India after violations were identified during an audit of the company’s manufacturing facility.

The agency said that although the products were registered, they have not been imported into Nigeria and warned that if any of the devices are found in circulation in the country would be considered falsified and fraudulently imported.

  • In another safety alert, NAFDAC recently directed the immediate withdrawal of multi-dose Artemether/Lumefantrine dry powder for oral suspension still in circulation across the country.
  • The agency also flagged a suspected revalidated SMA Gold infant formula discovered in Kaduna State after altered expiry dates were linked to illness in a four-month-old infant.

Another is on the circulation of falsified Dostinex 0.5mg tablets in Nigeria. The legitimate product is registered but not yet imported, while the fake batches, GG3470, LG8659, and GG2440 have no NAFDAC registration and may be unsafe.

Rosalia Ozibo

Rosalia Ozibo

Rosalia is a versatile journalist with a focus on technology and education. She has a talent for turning complex ideas into engaging stories, exploring how innovation and learning shape the future of people, business, and society. From tracking shifts in digital transformation and emerging tech to writing about developments in education policy and practice, her work bridges insight and accessibility. Known for sharp analysis and compelling storytelling, she continues to provide readers with perspectives that connect knowledge, opportunity, and the evolving world of work.

Next Post
Hand holding Nigerian Naira banknotes fanned out, representing currency exchange or financial context

Naira strengthens to N1,345/$, hits highest level in one month

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast

nairametrics




DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics